Rapport d'activité scientifique 2011 - Faculté de Pharmacie ...

disponible sur: http://www.intechopen.com/articles/show/title/biomimetic-synthesis-and-properties-ofpolyprenoid.
• Rognan, D. Docking methods for virtual screening: Principles and recent advances. In Virtual
Screening, C. Sotriffer, ed., Wiley-VCH, pp.153-169. (ISBN-13: 978-3-527-32636-5).
• Rognan, D. Exploiting fragment structural information in docking, virtual screening and design. In
Fragment-based drug discovery and X-ray crystallography, T. Davies and M. Hyvonen, eds.,
Springer.
• Rognan, D. In silico Chemogenomics, Chemical Genomics and Proteomics (2 nd Edition), F.
Darvas, A. Guttman, G. Dorman, eds., Taylor & Francis.
• Kellenberger, E.; Dejaegere, A. Molecular modeling of ligand-macromolecule complexes. In
Biophysical Approaches determining ligand binding to biomolecular targets: detection, measurement
and modelling, Podjarny, A.; Dejaegere, A.; Kieffer, B., Eds. Royal Society of Chemistry: 2011; pp
300-346.
• Taquet, N.; Philippe, C.; Reimund, JM.; Muller, CD. Inflammatory Bowel Disease G-Protein Coupled
Receptors (GPCRs) expression profiling with microfluidic cards, Chapter IX, 29 pages. Book title:
Crohn's Disease INTECH publish 2011 SBN: 979−953−307−137−3.
VIII. Ouvrages de vulgarisation (ou chapitres)
• Fleurentin, J.; Weniger, B.; Bourdy.; G.
Traditions thérapeutiques et médecine de demain, les enjeux de l'ethnopharmacologie
Editions Ouest France, 2011
• Kellenberger E.
Intervention radiophonique (podcast france culture et RFI, septembre 2011)
IX. Direction d'ouvrages
• Frossard N. Editeur associée de la revue Pharmacology & Therapeutics. Girodet P-O, Ozier A, Bara I,
Tunon de Lara J-M, Marthan R, Berger P. Airway remodeling in asthma: New mechanisms and
potential for pharmacological intervention. Pharmacol & Ther 2011, 130, 325-37.
• Frossard N. Editeur associée de la revue Pharmacology & Therapeutics (IF 8.8). Bellien J, Joannides
R, Richard V, Thuillez C. Modulation of cytochrome-derived epoxyeicosatrienoic acid pathway: a
promising pharmacological approach to revent endothelial dysfunction in cardiovascular diseases?
Pharmacol & Ther 2011, 131, 1-17.
• Frossard N. Editeur associée de la revue Pharmacology & Therapeutics. Botturi K, Langelot M, Lair D,
Pipet A, Pain M, Chesne J, Hassoun D, Lacoeuille Y, Cavaillès A, Magnan A. Preventing asthma
exacerbations: what are the targets ? Pharmacol & Ther 2011, 131, 114-129.
• Weniger B. Coéditeur de Ethnopharmacologia (Bulletin de la Société Française d'Ethnopharmacologie
et de la Société Européenne d'Ethnopharmacologie) 2006 à 2011
X. Autres publications